As if I weren’t already in a super mood from my recent test results (still grinning here in Kansas), I found that Santa had left me a little stocking stuffer in my e-mail. It seems the stock of the drug company that makes Pirfenidone, Intermune, just went up a nice little bit last week. Why?
Well, it seems that the phase III trial for idiopathic pulmonary fibrosis underway in Japan issued some preliminary results, and they were quite promising. Now, as soon as I’m finished with the holidays I plan to track down this research and read it for myself.
But, the knowledge that their trial is going well was just that little bit of extra good news for me Christmas morning. We seem to be on the right track.
Well, it seems that the phase III trial for idiopathic pulmonary fibrosis underway in Japan issued some preliminary results, and they were quite promising. Now, as soon as I’m finished with the holidays I plan to track down this research and read it for myself.
But, the knowledge that their trial is going well was just that little bit of extra good news for me Christmas morning. We seem to be on the right track.
Comments